Multi-target drugs should be in the pharma pipeline along with precision drugs
QUINN ROONEY/GETTY IMAGES
The pharmaceutical industry shouldn't overlook the development of multi-target drugs in its race to develop precision drugs that take aim at single targets.
No hay comentarios:
Publicar un comentario